Article Details

Improving Low-Intensity Therapy for Older Patients With AML - Targeted Oncology

Retrieved on: 2022-12-03 18:09:32

Tags for this article:

Click the tags to see associated articles and topics

Improving Low-Intensity Therapy for Older Patients With AML - Targeted Oncology. View article details on hiswai:

Excerpt

The antibody-drug conjugate gemtuzumab ozogamicin [Mylotarg] has also shown efficacy as an additional agent. Monoclonal antibodies being ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up